Uterine artery embolization
Minimally invasive procedure to treat fibroids
Uterine artery embolization (UAE) is a minimally invasive procedure used to treat uterine fibroids, which are non-cancerous growths in the uterus. The procedure involves blocking the blood supply to the fibroids, causing them to shrink and die.
Procedure[edit | edit source]
Uterine artery embolization is performed by an interventional radiologist. The procedure begins with the insertion of a catheter into the femoral artery in the groin. Using fluoroscopy, the catheter is guided to the uterine arteries. Once in place, small particles are injected to block the blood flow to the fibroids. This process is known as embolization.
The particles used in UAE are typically made of polyvinyl alcohol or other biocompatible materials. These particles lodge in the small blood vessels that supply the fibroids, effectively cutting off their blood supply. Over time, the fibroids shrink and symptoms improve.
Indications[edit | edit source]
Uterine artery embolization is primarily indicated for women who experience significant symptoms from fibroids, such as heavy menstrual bleeding, pelvic pain, or pressure symptoms. It is an alternative to surgical options like hysterectomy or myomectomy.
Benefits and Risks[edit | edit source]
The benefits of UAE include a shorter recovery time compared to surgical options, preservation of the uterus, and a high success rate in symptom relief. However, there are risks associated with the procedure, including infection, pain, and potential impacts on future fertility.
Recovery[edit | edit source]
Recovery from uterine artery embolization typically involves a short hospital stay, followed by a few days of rest at home. Most women can return to normal activities within one to two weeks. Pain and cramping are common in the first few days after the procedure and can be managed with medication.
Outcomes[edit | edit source]
Studies have shown that UAE is effective in reducing fibroid size and alleviating symptoms in the majority of patients. Long-term outcomes are generally positive, with many women experiencing significant improvement in quality of life.
Related pages[edit | edit source]
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
